HUP9903619A2 - 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény - Google Patents

5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény

Info

Publication number
HUP9903619A2
HUP9903619A2 HU9903619A HUP9903619A HUP9903619A2 HU P9903619 A2 HUP9903619 A2 HU P9903619A2 HU 9903619 A HU9903619 A HU 9903619A HU P9903619 A HUP9903619 A HU P9903619A HU P9903619 A2 HUP9903619 A2 HU P9903619A2
Authority
HU
Hungary
Prior art keywords
antagonist
5ht2c
pharmaceutical composition
composition containing
compounds
Prior art date
Application number
HU9903619A
Other languages
English (en)
Inventor
Thomas Paul Blackburn
Original Assignee
Smithkline Beecham Plc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc. filed Critical Smithkline Beecham Plc.
Publication of HUP9903619A2 publication Critical patent/HUP9903619A2/hu
Publication of HUP9903619A3 publication Critical patent/HUP9903619A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány 5HT2C és D2 antagonista aktivitással rendelkező vegyületekkombinációira, az említett receptorok mindegyikén aktivitássalrendelkező vegyületekre, az ilyen kombinációkat és vegyületekettartalmazó gyógyszerkészítményekre, valamint gyógyászatifelhasználásukra vonatkozik. Ó
HU9903619A 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist HUP9903619A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615767.2A GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment
PCT/EP1997/004159 WO1998004289A2 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist

Publications (2)

Publication Number Publication Date
HUP9903619A2 true HUP9903619A2 (hu) 2000-10-28
HUP9903619A3 HUP9903619A3 (en) 2001-03-28

Family

ID=10797573

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903619A HUP9903619A3 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist

Country Status (19)

Country Link
EP (1) EP0936924A2 (hu)
JP (1) JP2000516924A (hu)
KR (1) KR20000029564A (hu)
CN (1) CN1230894A (hu)
AR (1) AR008083A1 (hu)
AU (1) AU725817B2 (hu)
BR (1) BR9710568A (hu)
CA (1) CA2261813A1 (hu)
CO (1) CO5031292A1 (hu)
CZ (1) CZ23799A3 (hu)
GB (1) GB9615767D0 (hu)
HU (1) HUP9903619A3 (hu)
IL (1) IL128219A0 (hu)
NO (1) NO990322L (hu)
NZ (1) NZ333813A (hu)
PL (1) PL331426A1 (hu)
TR (1) TR199900140T2 (hu)
WO (1) WO1998004289A2 (hu)
ZA (1) ZA976593B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6348455B1 (en) 1998-11-23 2002-02-19 Sepracor Inc. Desmetylolanzapine compositions and methods
CA2352611A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
AU757870B2 (en) * 1998-11-23 2003-03-06 Sepracor, Inc. Pharmaceutical compositions containing olanzapine-N-oxide
JP2003525865A (ja) 1999-03-18 2003-09-02 チルドレンズ・ホスピタル・リサーチ・ファウンデイション 非定型抗精神病薬の投与による神経性過食症および関連摂食障害の治療方法
JP2003500353A (ja) * 1999-05-19 2003-01-07 アストラゼネカ・アクチエボラーグ 処置方法
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500998D0 (sv) * 1995-03-19 1995-03-19 Haakan Wilhelm Wikstroem New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

Also Published As

Publication number Publication date
WO1998004289A3 (en) 1998-03-19
IL128219A0 (en) 1999-11-30
NO990322L (no) 1999-03-24
CO5031292A1 (es) 2001-04-27
CZ23799A3 (cs) 1999-06-16
ZA976593B (en) 1999-01-25
AU725817B2 (en) 2000-10-19
AU4297297A (en) 1998-02-20
GB9615767D0 (en) 1996-09-04
KR20000029564A (ko) 2000-05-25
WO1998004289A2 (en) 1998-02-05
NZ333813A (en) 2000-07-28
HUP9903619A3 (en) 2001-03-28
CA2261813A1 (en) 1998-02-05
PL331426A1 (en) 1999-07-19
EP0936924A2 (en) 1999-08-25
CN1230894A (zh) 1999-10-06
NO990322D0 (no) 1999-01-25
AR008083A1 (es) 1999-12-09
BR9710568A (pt) 1999-08-17
JP2000516924A (ja) 2000-12-19
TR199900140T2 (xx) 1999-03-22

Similar Documents

Publication Publication Date Title
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
NO304887B1 (no) Endotelin-reseptor-antagonister, anvendelse derav og farmas°ytiske preparater inneholdende dem
PA8435001A1 (es) Derivados 6,6-heterobiciclicos sustituidos.
NO308298B1 (no) Substituerte kinazolinderivater, anvendelse derav og farmasøytiske preparater inneholdende dem
NO317747B1 (no) Farmasoytisk preparat samt anvendelse derav
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
EE03879B1 (et) LH-RH peptiidi analoogid, nende kasutamine ja neid sisaldavad farmatseutilised kompositsioonid
DE69836424D1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
ATE231872T1 (de) Thiazolopyrimidinderivate
IS3878A (is) Imidazodiazepines efnasambönd, framleiðsla þeirraog notkun sem lyfja
PT101444A (pt) Associacao sinergizante com efeito antagonista dos receptores nk1 e nk2, uso de produtos com actividade antagonista dos receptores nk1 e nk2 na sua preparacao e composicao farmaceutica contendo a referida associacao
HUP9903619A2 (hu) 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
HUP0002346A1 (hu) Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
ATE28188T1 (de) Antikonvulsive mittel.
AR002978A1 (es) Compuestos benzamidas, composiciones farmacéuticasque los contienen, metodos para preparar los mismos y el uso de los mismos.
EE9700230A (et) Bitsüklilised tahhükiniini antagonistid, nende valmistamine ja kasutamine ravimsegus
EE9900174A (et) Konformatsiooniliselt fikseeritud LH-RH analoogid, nende kasutamine ja neid sisaldavad farmatseutilised kompositsioonid
HU9802590D0 (en) Sulfonamid-substituted and condensed compounds containing 5-membred ring, their use as medicament and pharmaceutical compositions containing them
DE3674971D1 (en) P-acylaminobenzamide.
IS4733A (is) Ný LH-RH mótlyf, framleiðsla þeirra og notkun, ásamt læknislyfjum sem innihalda samsetningarnar og framleiðsla þeirra
ES2186909T3 (es) Agentes antipaludicos y antibabesiosis y composiciones farmaceuticas que los contienen.
NO942228D0 (no) Ipsapiron-legemiddeltilberedning